510(k) K780335
K780335 is an FDA 510(k) premarket notification submitted by Hyland Therapeutic Div., Travenol Laboratories for the device "LAS-R HUMAN C1 ESTERASE INHIBITOR TEST". The FDA issued a decision of Substantially Equivalent on Mar 22, 1978. The device falls under product code DBA (Complement C1 Inhibitor (Inactivator), Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5250. Hyland Therapeutic Div., Travenol Laboratories has 43 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 22, 1978
- Date Received
- Feb 28, 1978
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Complement C1 Inhibitor (Inactivator), Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5250
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Hyland Therapeutic Div., Travenol Laboratories? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.